IL18 and breast carcinoma: Nevertheless, it is worth noting that the serum level of IL-18 declined in patients with thickened endometrium after tamoxifen therapy for breast cancer, which is a risk for the tumorigenesis of EC, indicating that IL-18 may be downregulated in tamoxifen-derived EC (41).